Abstract
A hospital in-patient died 7 days after administration of radioiodine for treatment of thyroid cancer. Radioiodine is widely used in treatment of thyroid cancer, but death of a patient shortly after treatment is very unusual. This presented a number of challenging radiation protection issues including: dealing with staff involved with the care of the patient before and after death; and advising on release of the body for burial or cremation. Dose rate measurements were performed at a number of time points and used to inform a risk assessment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
